GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma
Clinical trial NCT06827886 · COMPLETED
Trial details
- NCT number
- NCT06827886
- Sponsor
- AHS Cancer Control Alberta
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-06
- Primary completion
- 2024-09-09
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.